[go: up one dir, main page]

CA2793045A1 - Huile de boswellia, ses fractions et compositions pour augmenter la fonction cerebrale - Google Patents

Huile de boswellia, ses fractions et compositions pour augmenter la fonction cerebrale Download PDF

Info

Publication number
CA2793045A1
CA2793045A1 CA2793045A CA2793045A CA2793045A1 CA 2793045 A1 CA2793045 A1 CA 2793045A1 CA 2793045 A CA2793045 A CA 2793045A CA 2793045 A CA2793045 A CA 2793045A CA 2793045 A1 CA2793045 A1 CA 2793045A1
Authority
CA
Canada
Prior art keywords
boswellia
extract
fraction
composition
memory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2793045A
Other languages
English (en)
Inventor
Ganga Raju Gokaraju
Rama Raju Gokaraju
Venkata Kanaka Ranga Raju Gokaraju
Trimurtulu Golakoti
Kiran Bhupathiraju
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laila Nutraceuticals
Original Assignee
Laila Nutraceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laila Nutraceuticals filed Critical Laila Nutraceuticals
Publication of CA2793045A1 publication Critical patent/CA2793045A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
CA2793045A 2010-03-15 2011-03-14 Huile de boswellia, ses fractions et compositions pour augmenter la fonction cerebrale Abandoned CA2793045A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN687/CHE/2010 2010-03-15
PCT/IN2011/000170 WO2011114350A2 (fr) 2010-03-15 2011-03-14 Huile de boswellia, ses fractions et compositions pour augmenter la fonction cérébrale
IN687CH2010 IN2010CH00687A (fr) 2010-03-15 2011-03-14

Publications (1)

Publication Number Publication Date
CA2793045A1 true CA2793045A1 (fr) 2011-09-22

Family

ID=54291846

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2793045A Abandoned CA2793045A1 (fr) 2010-03-15 2011-03-14 Huile de boswellia, ses fractions et compositions pour augmenter la fonction cerebrale

Country Status (8)

Country Link
CN (1) CN102811728A (fr)
AU (2) AU2011228689A1 (fr)
BR (1) BR112012022983A2 (fr)
CA (1) CA2793045A1 (fr)
IN (1) IN2010CH00687A (fr)
MY (1) MY173288A (fr)
SG (1) SG184006A1 (fr)
WO (1) WO2011114350A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169297A (en) * 2010-05-30 2019-03-21 Laila Nutraceuticals Compositions comprising non-acidic boswellia oil fraction as a bio-enhancer for enhancing the bioavailability of biological agents
GB201111319D0 (en) 2011-07-04 2011-08-17 Univ Leuven Kath Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa
JP6985139B2 (ja) * 2014-10-21 2021-12-22 アルピニア・ローダナム・インスティテュート・オブ・フィトファーマシューティカル・サイエンシーズ・アクチェンゲゼルシャフトAlpinia Laudanum Institute Of Phytopharmaceutical Sciences Ag ボスウェリア属の植物に由来する抽出物、並びに関連する生成物及び使用
JP6936151B2 (ja) 2015-04-13 2021-09-15 エトノディーヌ α−シヌクレイノパチーの治療のためのアシュワガンダ抽出物の使用
CN113855656A (zh) * 2017-05-16 2021-12-31 四川省中医药科学院 四氢姜黄素在制备提高记忆力的药物或保健品中的用途
CN107349190B (zh) * 2017-07-19 2021-04-23 广东工业大学 芳姜黄酮的应用
IT201900013707A1 (it) * 2019-08-01 2021-02-01 Cristalfarma S R L Integratore alimentare, per uso come coadiuvante, per la prevenzione della demenza vascolare
EP4114204A4 (fr) * 2020-03-03 2024-01-10 Laila Nutraceuticals Compositions synergiques pour améliorer la santé cérébrale
WO2021205083A2 (fr) 2020-04-11 2021-10-14 Finindsutria Srl Composition pour la prévention ou le traitement du covid-19
CN116370523B (zh) * 2023-04-04 2024-08-13 昆明理工大学 植物精油在制备抗癫痫药物或健康产品中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444288A1 (de) * 1994-12-13 1996-06-20 Rainer Dr Med Etzel Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit
US20070248693A1 (en) * 2003-08-02 2007-10-25 Elizabeth Mazzio Nutraceutical composition and method of use for treatment / prevention of cancer
US7873730B2 (en) * 2003-11-10 2011-01-18 International Business Machines Corporation Method and system for collaborative computing environment access restriction and orphan data management
CN1583063B (zh) * 2004-06-10 2012-03-28 山东齐都药业有限公司 乳香有效成分提取方法及提取物制剂和用途
WO2008036932A2 (fr) * 2006-09-21 2008-03-27 Herbalscience Singapore Pte. Ltd. Compositions et procédés utilisant l'espèce boswellia

Also Published As

Publication number Publication date
AU2011228689A1 (en) 2012-09-27
WO2011114350A3 (fr) 2011-11-10
WO2011114350A2 (fr) 2011-09-22
CN102811728A (zh) 2012-12-05
AU2016201084A1 (en) 2016-03-17
AU2016201084B2 (en) 2017-10-19
SG184006A1 (en) 2012-10-30
IN2010CH00687A (fr) 2011-08-31
BR112012022983A2 (pt) 2015-09-15
MY173288A (en) 2020-01-13

Similar Documents

Publication Publication Date Title
AU2016201084B2 (en) Boswellia Oil, Its Fractions And Compositions For Enhancing Brain Function
US9795646B2 (en) Boswellia oil, its fractions and compositions for enhancing brain function
EP2536288B1 (fr) Nouvel extrait de résine de gomme faiblement polaire de boswellia et ses compositions synergiques
Basri et al. A review on the pharmacological activities and phytochemicals of Alpinia officinarum (Galangal) extracts derived from bioassay-guided fractionation and isolation
Patocka et al. Achillea fragrantissima: pharmacology review
Koynova et al. Natural product formulations for the prevention and treatment of Alzheimer's disease: a patent review
KR20100082044A (ko) 생강 또는 건강 추출물을 유효성분으로 함유하는 건망증 및기억력 장애 관련 질환의 예방 및 치료용 조성물
US20210128656A1 (en) Composition containing poria cocos peel extract for treating neurodegenerative disorders
KR100890179B1 (ko) 현삼 추출물을 유효성분으로 함유하는 인지기능 장애 관련질환의 예방 및 치료용 조성물
CN102905529B (zh) 含有非酸性乳香油分馏物的组合物作为用于提高生物制剂的生物利用度的生物增强剂
EP3538121A1 (fr) Compositions de complément alimentaire synergique pour améliorer la santé cérébrale
Yuca et al. Matricaria chamomilla L.
US11357810B2 (en) Compositions with purified Bombyx mori cocoon silk peptide fiber and refined Buglossoides arvensis seed oil having synergistic effects for improving memory, focus, and cognitive function, and related methods
US12194071B2 (en) Methods and compositions with purified Bombyx mori cocoon silk peptide fiber and refined Buglossoides arvensis seed oil providing anti-inflammatory effects and neuroprotection for disease states
JP2020508962A (ja) 神経新生の促進を通して脳の健康を改善するための植物抽出物の使用
KR20100014989A (ko) 진저롤을 유효성분으로 함유하는 기억력 및 인지기능 장애관련 질환의 예방 및 치료용 조성물
Venkata Ratnam et al. Herbal Drugs: Its Mechanism to Prevent Alzheimer’s Disease with Special Reference to Non-phenolic Secondary Metabolites
KR20230168731A (ko) 침향 추출물을 포함하는 기억력 또는 인지기능 개선용 조성물
Hulle et al. Effect of Combination of Polyherbal Extracts for treatment of Hyperlipidemia using Animal Model
US20250170196A1 (en) Anti-inflammatory, immunomodulatory and analgesic agents from tree exudates
Abdulkhader et al. Journal of Pharmacy & Allied Medicine
Ahmad et al. Therapeutic Potential of Widely Used Unani Drug Asl-Us-Soos (Glycyrrhiza glabra Linn.): A Systematic Review

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160309

FZDE Discontinued

Effective date: 20190314